Status:
UNKNOWN
Therapy of Age-related Macular Degeneration
Lead Sponsor:
Robert Hörantner
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
Brief Summary
People with the disease age-related macular degeneration (AMD) are treated with the Medical Eye Trainer (MET) system to improve their vision. The training is carried out over 2 months.
Detailed Description
Age-related macular degeneration (AMD) is a widespread eye disease worldwide. According to the Gutenberg Health Study, about 7000000 people in Germany suffer from it. The numbers for Austria are to be...
Eligibility Criteria
Inclusion
- Age-related macular degeneration
Exclusion
- Epilepsy
- Double vision
Key Trial Info
Start Date :
February 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05222997
Start Date
February 28 2022
End Date
April 30 2023
Last Update
August 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BHS Ried
Ried im Innkreis, Upperaustria, Austria, A - 4910